newsfilter
← Latest News
PR Newswire·

Leap Therapeutics to Participate at the Piper Sandler 34th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 21, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi,